Tethered endoscopy (from mouth) and colonoscopy (from rectum) is a painful, unpleasant, and time-consuming process recommended for gastrointestinal diseases or disorders. Even by administering tethered endoscopy or colonoscopy, most of the small bowel remains inaccessible and always MDs recommend alternative invasive diagnosis methods such as surgery or MRI. The small bowel is one of the most inaccessible organs in the human body because of the long length, narrow diameter and too many folds.

Solution
The company is proposing a unique solution for the above problem; a robotic capsule for endoscopy, biopsy and microbiota sampling of the small intestine for diagnosis, detection and prediction of disorders and diseases.

The main principles for this device is:

• Endoscopy and biopsy simultaneously
• Capsule is carrying biopsy needles
• Take out the sample for further examinations & pathology

The company's innovative capsule is working in real-time mode instantly and communicates via a smartphone application while streaming live images. During the process, an MD could trigger the biopsy with a smartphone and biopsy needles come out and take a sample of tissue, carrying it inside a capsule for further examination and pathology.

Market
The potential market and primary customers of this product would be internal organ specialists, hospitals, surgical and medical centres.

Financials
So far, a total of 135,000 € has been raised as an equity investment and also with the founder’s self-funding of 85,000 € research and development, IPR matters, administrations, purchasing, wages, prototype fabrication and orders have been done. At this stage, the company planned an investment of 500,000 € for newly released 500.000 total shares with a minimum ticket size of 25,000 €. The raised capital would be added to the above. The company is looking for a pre-seed investment of 500,000 € at this stage to boost for a five-year plan of commercialization with the capabilities of almost 5,000,000 € turnover in year five and 10,000,000 € gross overall.

Sell Reason
Attract capital for further growth

Stake offered
To be discussed

Transaction form
To be discussed

Suitable for
Strategic buyers, financial investors and MBI candidates